Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.
Board-certified in dermatology, Dr. Jones received his medical degree from Baylor College of Medicine in Houston, TX, and completed his dermatology residency at Columbia University in New York City, where he served as Chief Resident. In 1999 he founded Skin Care and Laser Physicians of Beverly Hills, where he is the Director. Dr. Jones is currently Director of an American Society for Dermatologic Surgery (ASDS) Cosmetic Fellowship, and for 20 years prior was Clinical Associate Professor of Medicine at the University of California, Los Angeles. Dr. Jones is an internationally regarded key opinion leader and researcher on cosmetic injectables. He is frequently an invited speaker at national dermatology meetings and has delivered over 300 scholarly lectures internationally.
Dr. Jones is a widely published author, with more than 110 publications in leading peer-reviewed medical journals. He has written several textbook chapters and is Editor of the textbook Injectable Fillers: Principles and Practice (Wiley-Blackwell), and the upcoming Injectable Fillers: Facial Contouring and Sculpting (Wiley-Blackwell). Dr. Jones is an Assistant Editor for Journal of Dermatologic Surgery. Dr. Jones served as the lead investigator on the Juvederm Voluma® and Kybella trials that led to FDA approval. He has been a principal investigator on many clinical trials in facial aesthetics, including the trials that led to FDA approval of Juvéderm® , Latisse®, Belotero®, Xeomin®, Restylane Refyne® and Radiesse® for hands, as well as 2 other Phase 3 studies of novel neurotoxins. Dr. Jones is a fellow of the American Academy of Dermatology and ASDS, and has filled numerous leadership roles for ASDS, including 3 years on the Board of Directors.